Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Radiother Oncol. 2016 Jul 6;120(2):349–355. doi: 10.1016/j.radonc.2016.06.010

Table 4.

DVH metrics for the clinical plan and the Rapidplan® re-plan for patient 291 at RS2. While the metrics were noticeably high for the original plan, re-planning resulted in values much closer to the model prediction.

Patient #291 Clinical Replan
PTV Max (Gy) 56.9 53.2
D95% (Gy) 50.7 50.4
Lungs V40Gy (%) 2.2 1.4
V30Gy (%) 6.1 3.1
V20Gy (%) 16.2 11.8
V10Gy (%) 24.7 19.1
P (%) 54.3% 68.1%
F (%) 66.4% 8.7%
gEUD (Gy) 8.1 7.3
mRSR (Gy) 0.3 −0.3
Heart V30Gy (%) 28.2 17.7
Mean (Gy) 23.1 18.7
P (%) 98.3% 23.5%
F (%) 100% 56.5%
gEUD (Gy) 24.1 20.7
mRSR (Gy) 2.3 0.0
Liver V30Gy (%) 11.4 6.3
V20Gy (%) 40.7 33.3
Mean (Gy) 14.8 12.5
P (%) 84.2% 27.4%
F (%) 100% 100%
mRSR (Gy) 2.1 0.5
Stomach Mean (Gy) 9.1 7.4
P (%) 65.9% 19.3%
F (%) 100.0% 51.0%
gEUD (Gy) 43.6 41.4
mRSR (Gy) 2.5 0.1